SWEDISH ORPHAN BIOVITRUM AB (PUBL)

Italy

All drugs from this manufacturer

  • ALPROLIX

    It is used for the treatment and prevention of bleeding in patients of all ages with hemophilia B, a hereditary disease caused by a deficiency of factor IX.

    Dosage form: solution for injection, powder and solvent

    Active substance Dosage
    eftrenonacog alfa -

    ATC: B02BD04

  • It is used for the treatment and prevention of bleeding episodes in patients with hemophilia A, a hereditary disorder caused by the deficiency or dysfunction of factor VIII.

    Dosage form: solution for injection, powder and solvent

    Active substance Dosage
    efanesoctocog alfa -

    ATC: B02BD02

  • It is used to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who present with anemia due to this disease. It is also indicated for adults and adolescents (between 12 and 17 years old) with C3 glomerulopathy (C3G) or immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN).

    Dosage form: solution for infusion

    Active substance Dosage
    pegcetacoplan -

    ATC: L04AJ03

  • It is used in adults with chronic liver disease to treat low platelet counts before a medical procedure with a risk of bleeding. It is also indicated for treating adults with primary chronic immune thrombocytopenia (ITP) when other treatments have not been sufficient.

    Dosage form: tablets, film-coated

    Active substance Dosage
    avatrombopag -

    ATC: B02BX08

  • It is used for the treatment and prevention of bleeding in patients of all ages with hemophilia A, a hereditary disease caused by a deficiency of factor VIII.

    Dosage form: solution for injection, powder and solvent

    Active substance Dosage
    efmoroctocog alfa -

    ATC: B02BD02

  • Kineret is used to treat rheumatoid arthritis in adults, hyperinflammation associated with COVID-19 in patients with pneumonia requiring oxygen, periodic fever syndromes (such as familial Mediterranean fever, Still's disease, and cryopyrin-associated periodic syndromes), and Still's disease.

    Dosage form: solution for injection

    Active substance Dosage
    anakinra -

    ATC: L04AC03

  • It is a lipid-lowering medicinal product used, together with a specific diet, to treat people over 18 years of age suffering from familial chylomicronemia syndrome (FCS), a hereditary disease that causes excessively high triglyceride levels in the blood.

    Dosage form: solution for injection, in pre-filled pen

    Active substance Dosage
    olezarsen -

    ATC: C10AX

  • Zynlonta is a medicine used to treat adults with a type of cancer called diffuse large B-cell lymphoma (DLBCL), in cases where the cancer has returned after two or more treatments or has not responded to previous therapies.

    Dosage form: powder for concentrate for infusion solution

    Active substance Dosage
    loncastuximab tesirine -

    ATC: L01FX22